Lipidemia
Clinical trials for Lipidemia explained in plain language.
Never miss a new study
Get alerted when new Lipidemia trials appear
Sign up with your email to follow new studies for Lipidemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control OngoingThis Phase 3 study tests whether a daily pill combining obicetrapib and ezetimibe, or obicetrapib alone, can lower LDL (bad) cholesterol more than placebo in 300 people with type 2 diabetes or metabolic syndrome. Participants continue their standard cholesterol medications. The m…
Matched conditions: LIPIDEMIA
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill could melt away heart disease plaque, major trial underway
Disease control OngoingThis study tests a daily pill (obicetrapib plus ezetimibe) to see if it can reduce fatty plaque buildup in the arteries of 300 adults with heart disease. Participants must already be on cholesterol-lowering therapy but still have high LDL cholesterol and measurable plaque. The tr…
Matched conditions: LIPIDEMIA
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC